Dexcom G7 Continuous Glucose Monitoring System

Integrated Continuous Glucose Monitoring System, Factory Calibrated

Dexcom, Inc.

The following data is part of a premarket notification filed by Dexcom, Inc. with the FDA for Dexcom G7 Continuous Glucose Monitoring System.

Pre-market Notification Details

Device IDK213919
510k NumberK213919
Device Name:Dexcom G7 Continuous Glucose Monitoring System
ClassificationIntegrated Continuous Glucose Monitoring System, Factory Calibrated
Applicant Dexcom, Inc. 6340 Sequence Dr. San Diego,  CA  92121
ContactNeeta Sharma
CorrespondentHolly Drake
Dexcom, Inc. 6340 Sequence Dr. San Diego,  CA  92121
Product CodeQBJ  
CFR Regulation Number862.1355 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2021-12-15
Decision Date2022-12-07

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00386270003416 K213919 000
00386270003430 K213919 000
00386270003423 K213919 000
00386270002815 K213919 000
00386270003676 K213919 000
00386270003591 K213919 000
00386270003621 K213919 000
00386270003614 K213919 000
00386270003478 K213919 000
00386270004017 K213919 000
00386270003386 K213919 000
00386270001863 K213919 000
00386270003294 K213919 000
00386270002839 K213919 000
00386270002822 K213919 000
00386270002525 K213919 000
00386270002518 K213919 000
00386270002198 K213919 000
00386270002808 K213919 000
00386270002174 K213919 000
00386270001870 K213919 000
00386270000378 K213919 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.